Zepbound 2.5 mg/0.5 mL Pen

Description

Zepbound 2.5 mg/0.5 mL Pen is the starting dose of tirzepatide, a once-weekly GLP-1/GIP dual agonist used to support significant weight loss in adults with obesity or overweight conditions. This introductory dose is crucial for minimizing gastrointestinal side effects as your body adjusts to treatment. With its user-friendly, prefilled auto-injector, Zepbound makes it simple to begin your weight management journey.

💊 Key Features of Zepbound 2.5 mg

• Contains 2.5 mg of tirzepatide in a 0.5 mL single-use pen

• Once-weekly subcutaneous injection

• Easy-to-use auto-injector — no needle handling required

• Designed as the starting dose before escalating to higher strengths

• Dual-action formula targets appetite, satiety, and metabolism

📦 What’s Inside

• 1 or 4 single-use pens (2.5 mg/0.5 mL each)

• Prefilled, ready-to-use auto-injectors

• Step-by-step user instructions for safe and effective injection

🌟 Benefits

• Helps your body adjust to tirzepatide while minimizing side effects

• Prepares you for higher weight-loss doses (5 mg and above)

• Dual-hormone mechanism regulates appetite and energy use

• Supports consistent, doctor-guided weight management

🩺 How to Use

• Inject subcutaneously once a week on the same day each week

• Administer in the abdomen, thigh, or upper arm (rotate sites)

• Use this 2.5 mg dose for the first 4 weeks before increasing to 5 mg or as directed by your doctor

• Do not reuse pens — each is single-use only

⚠️ Safety Information / Warnings

• Not for use in patients with personal or family history of medullary thyroid cancer or MEN 2

• May cause nausea, vomiting, diarrhea, or constipation, especially during early use

• Monitor for signs of pancreatitis or severe gastrointestinal issues

• Not recommended for use with other GLP-1 medications

• Inform your doctor about all medications and conditions before starting

❄️ Storage & Handling

• Store pens in the refrigerator (36°F to 46°F / 2°C to 8°C)

• May be kept at room temperature (up to 86°F / 30°C) for up to 21 days

• Do not freeze or expose to direct heat or sunlight

• Dispose of used pens in a sharps container

❓ Frequently Asked Questions

Q: Is this the dose that helps with weight loss?
A: The 2.5 mg dose is primarily for tolerability. Weight loss effects increase with higher doses prescribed after the initial 4 weeks.

Q: Can I stay on 2.5 mg long-term?
A: No, this is a starter dose. Your doctor will typically increase it to 5 mg or more after 4 weeks.

Q: Will I feel side effects immediately?
A: Some users experience mild GI symptoms like nausea, but this dose is designed to minimize that risk.

Q: Can I inject it anywhere?
A: Inject into your abdomen, thigh, or upper arm, rotating the site each week for comfort and safety.

Q: Can Zepbound be prescribed for sleep apnea?
A: On December 20, 2024, FDA approved Zepbound (tirzepatide) for the treatment of obstructive sleep apnea in adults with obesity, to be used in combination with a reduced calorie diet and increased physical activity. This makes Zepbound the first drug treatment option for certain patients with sleep apnea.

Q: Are Zepbound and Mounjaro the same
A: Mounjaro and Zepbound are brand names for the same drug, tirzepatide. While Mounjaro is approved for type 2 diabetes, Zepbound is approved for weight management in adults with a BMI of 30 or more. It’s also approved if you’re overweight and have another health condition including: High blood pressure.

Q: Can you drink Alcohol while taking Zepbound?
A: While Zepbound (tirzepatide) doesn’t have any known direct interactions with alcohol, it’s generally not recommended to drink while taking it. Alcohol can worsen some of Zepbound’s side effects, like nausea, and may also interfere with weight loss efforts. If you choose to drink, it’s best to do so in moderation and after consulting with your doctor. 

Q: Are Ozempic and Zepbound the same?
A: Zepbound is the weight loss version of tirzepatide, and Ozempic is the diabetes version of semaglutide. Some confusion exists about Ozempic’s purpose because it gained popularity when celebrities started using it “off-label” for weight loss rather than diabetes treatment. However, we’ll answer the question as asked.